Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Regard Raises $15.3 Million Series A to Accurately and Quickly Uncover Patient Diagnoses
Regard (formerly known as HealthTensor), a software company developing an artificial intelligence (AI) co-pilot for physicians […]
Dunad Therapeutics Appoints Industry Veteran Pearl Huang as Chief Executive Officer
Dunad Therapeutics, a biopharmaceutical company developing small molecule covalent therapies based on novel insights from […]
Swing Therapeutics Selects Curavit to Provide Virtual Trial Site Services for Novel Digital Therapeutic Study for Fibromyalgia
Curavit Clinical Research, a virtual contract research organization (VCRO), has been selected by digital therapeutics company, Swing […]
Cepheid and BioGX Announce Collaboration to Develop Monkeypox PCR Test for the GeneXpert® System
Cepheid and BioGX today announced a collaboration between the two companies to deliver a PCR […]
INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect […]
Centerline Biomedical Raises $33 Million in Series B Financing
Centerline Biomedical, Inc. (Centerline), a private medical technology company, announced the closing of a $33 million Series […]
Cordio Medical Raises $18 Million in Funding From Ceros and Peregrine Ventures to Accelerate Growth
Cordio Medical, a market-leading medical speech processing platform, announced its latest successful strategic investment round […]
ObvioHealth Expands Digital Health Research Ecosystem Through New Global Licensing Agreement With Dedalus
ObvioHealth, a global virtual research organization (VRO), extends its strategic alliance with Dedalus Group (“Dedalus”), […]
Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma
Antengene Corporation Limited (“Antengene“ SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, […]
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
Echosens, a high-technology company offering liver diagnostic solutions, and Novo Nordisk A/S, a leading global […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more